Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
300
Trial Size
0.00 0 miles
Evaluation of a Community Health Worker (CHW)-Led Program University of Michigan Recruiting N/A
250
Trial Size
0.00 0 miles
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Children's Oncology Group Recruiting
1
Trial Phase
51
Trial Size
1.51 2 miles
Hypothermia's Impact on Pharmacology Children's Hospital of Philadelphia Recruiting N/A
41
Trial Size
2.17 2 miles
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Dana-Farber Cancer Institute Recruiting
3
Trial Phase
660
Trial Size
2.17 2 miles
Double Cord Versus Haploidentical (BMT CTN 1101) Medical College of Wisconsin Recruiting
3
Trial Phase
410
Trial Size
2.17 2 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
2.17 2 miles
Double-Blind Placebo-Controlled CIN Trial University of Michigan Recruiting
4
Trial Phase
163
Trial Size
2.17 2 miles
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool University of Michigan Recruiting N/A
444
Trial Size
2.17 2 miles
PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children Duke University Recruiting
1
Trial Phase
54
Trial Size
2.17 2 miles
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
107
Trial Size
2.17 2 miles
A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) OncoMed Pharmaceuticals, Inc. Recruiting
1
Trial Phase
80
Trial Size
2.17 2 miles
SVRII Family Factors Study Medical College of Wisconsin Recruiting N/A
250
Trial Size
2.17 2 miles
Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-versus-Host Disease National Cancer Institute (NCI) Recruiting N/A
12
Trial Size
2.17 2 miles
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
3
Trial Phase
4895
Trial Size
2.17 2 miles
Scleroderma Treatment With Autologous Transplant (STAT) Study Fred Hutchinson Cancer Research Center Recruiting
2
Trial Phase
30
Trial Size
2.17 2 miles
Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease University of Michigan Recruiting N/A
50
Trial Size
2.17 2 miles
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1900
Trial Size
2.17 2 miles
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Allergan Recruiting
3
Trial Phase
600
Trial Size
2.17 2 miles
Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Florine-18 Fluorodeoxyglucose in Normal Volunteers University of Michigan Recruiting
1
Trial Phase
145
Trial Size
2.17 2 miles
Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma University of Michigan Cancer Center Recruiting
2
Trial Phase
50
Trial Size
2.17 2 miles
The EVICEL® Neurosurgery Phase III Study Ethicon, Inc. Recruiting
3
Trial Phase
230
Trial Size
2.17 2 miles
Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection OrthoCarolina Research Institute, Inc. Recruiting
4
Trial Phase
206
Trial Size
2.17 2 miles
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC University of Michigan Cancer Center Recruiting
0
Trial Phase
12
Trial Size
2.17 2 miles
Heart And Lung Failure - Pediatric INsulin Titration Trial Children's Hospital Boston Recruiting
3
Trial Phase
1414
Trial Size
2.17 2 miles
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma National Cancer Institute (NCI) Recruiting
1
Trial Phase
62
Trial Size
2.17 2 miles
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 Leading BioSciences, Inc Recruiting
2
Trial Phase
260
Trial Size
2.17 2 miles
Non-Heme Iron Load Quantification in the Brain on MRI in Patients With Hemorrhagic Stroke University of Michigan Recruiting N/A
10
Trial Size
2.17 2 miles
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Halozyme Therapeutics Recruiting
2
Trial Phase
237
Trial Size
2.17 2 miles
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
500
Trial Size
2.17 2 miles
A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures University of Michigan Recruiting
3
Trial Phase
623
Trial Size
2.17 2 miles
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure University of Texas Southwestern Medical Center Recruiting
2
Trial Phase
36
Trial Size
2.17 2 miles
CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease The Cleveland Clinic Recruiting N/A
526
Trial Size
2.17 2 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
2.17 2 miles
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
2.17 2 miles
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
27
Trial Size
2.17 2 miles
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control University of Michigan Recruiting N/A
30
Trial Size
2.17 2 miles
Electronic Bridge to Mental Health for College Students University of Michigan Recruiting N/A
4394
Trial Size
2.17 2 miles
Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation University of Michigan Recruiting N/A
60
Trial Size
2.17 2 miles
Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus University of Michigan Recruiting
1
Trial Phase
50
Trial Size
2.17 2 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
2.17 2 miles
Gastric Gluten-Degradation Activity of PvP001 University of Michigan Recruiting
1
Trial Phase
30
Trial Size
2.17 2 miles
Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis University of Michigan Recruiting N/A
8
Trial Size
2.17 2 miles
Effect of Exercise and Surgical Weight Loss on Polyneuropathy University of Michigan Recruiting N/A
140
Trial Size
2.17 2 miles
Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts University of Michigan Recruiting N/A
100
Trial Size
2.17 2 miles
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Exact Sciences Corporation Recruiting N/A
1500
Trial Size
2.17 2 miles
Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM) Emory University Recruiting N/A
1206
Trial Size
2.17 2 miles
Long-term Surgical Therapeutic Outcomes of Peri-Implantitis University of Michigan Recruiting N/A
60
Trial Size
2.17 2 miles
A Long-term Extension Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients Assembly Biosciences Recruiting
2
Trial Phase
100
Trial Size
2.17 2 miles
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome Urovant Sciences GmbH Recruiting
2
Trial Phase
200
Trial Size
2.17 2 miles
ATHN 8: PUPs Matter Study American Thrombosis and Hemostasis Network Recruiting N/A
250
Trial Size
2.17 2 miles
Treatment of Persistent Cough in IPF With Inhaled RVT-1601 Respivant Sciences Inc. Recruiting
2
Trial Phase
180
Trial Size
2.17 2 miles
Identification of Biomarkers in Spinocerebellar Ataxia 3 University of Michigan Recruiting N/A
200
Trial Size
2.17 2 miles
ASSURE WCD Clinical Evaluation - Detection and Safety Study Kestra Medical Technologies, Inc. Recruiting N/A
130
Trial Size
2.17 2 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
2.17 2 miles
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
200
Trial Size
2.29 2 miles
Modulation of GABA-A Receptors in Parkinson Disease-Clarithromycin Arm University of Michigan Recruiting
1
Trial Phase
30
Trial Size
2.29 2 miles
Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm University of Michigan Recruiting
1
Trial Phase
30
Trial Size
2.29 2 miles
Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors University of Rochester Recruiting
3
Trial Phase
422
Trial Size
2.29 2 miles
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Neurotech Pharmaceuticals Recruiting
1
Trial Phase
170
Trial Size
3.34 3 miles
VX15/2503 Treatment for Huntington's Disease Vaccinex Inc. Recruiting
2
Trial Phase
84
Trial Size
3.34 3 miles
Specular Microscopy Study University of Michigan Recruiting N/A
75
Trial Size
3.34 3 miles
Enhancing Informal Caregiving to Support Diabetes Self-Management University of Michigan Recruiting N/A
890
Trial Size
3.34 3 miles
CCT for Diabetic Elderly Veterans Department of Veterans Affairs Recruiting N/A
400
Trial Size
3.34 3 miles
Telescope Exchange Study VisionCare, Inc. Recruiting N/A
75
Trial Size
3.34 3 miles
Stimulation to Undermine Dementia University of Michigan Recruiting N/A
140
Trial Size
3.34 3 miles
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Menlo Therapeutics Inc. Recruiting
3
Trial Phase
400
Trial Size
4.60 5 miles
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Menlo Therapeutics Inc. Recruiting
3
Trial Phase
200
Trial Size
4.60 5 miles
Triathlon Tritanium Knee Outcomes Study Stryker Orthopaedics Recruiting N/A
500
Trial Size
5.43 5 miles
Connect® MM- The Multiple Myeloma Disease Registry Celgene Corporation Recruiting N/A
3000
Trial Size
19.25 19 miles
A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers DEKK-TEC, Inc. Available N/A
0
Trial Size
23.65 24 miles
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection Seres Health Inc Available
2
Trial Phase
29
Trial Size
25.45 25 miles
A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease IMPAX Laboratories, Inc. Recruiting
2
Trial Phase
51
Trial Size
25.45 25 miles
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures GlaxoSmithKline Recruiting
4
Trial Phase
100
Trial Size
25.45 25 miles
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease Otonomy, Inc. Recruiting
3
Trial Phase
160
Trial Size
25.45 25 miles
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of FN-1501 Monotherapy in Patients With Advanced Solid Tumors Shanghai Fosun Pharmaceutical Development Co, Ltd. Recruiting
1
Trial Phase
33
Trial Size
25.45 25 miles
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine Geistlich Pharma AG Recruiting
1
Trial Phase
54
Trial Size
25.45 25 miles
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma Ascension South East Michigan Recruiting N/A
6
Trial Size
25.45 25 miles
Telemonitoring Enhanced Support for Depression Self Management University of Michigan Recruiting
3
Trial Phase
270
Trial Size
26.07 26 miles
Transcranial Direct Current Stimulation (tDCS) and Intensive Therapy in Aphasia University of Michigan Recruiting N/A
100
Trial Size
26.07 26 miles
Telavancin Observational Use Registry (TOUR) Theravance Biopharma Antibiotics, Inc. Recruiting N/A
1000
Trial Size
28.73 29 miles
Cerebral Oximetry in Critically Ill Patients Wayne State University Recruiting N/A
500
Trial Size
29.21 29 miles
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli Kaye, Keith, M.D., M.P.H. Recruiting
3
Trial Phase
444
Trial Size
33.48 33 miles
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Allergan Recruiting
2
Trial Phase
116
Trial Size
33.48 33 miles
Compassionate Use of Stanate (TM) [Stannsoporfin] InfaCare Pharmaceuticals Corporation Available N/A
50
Trial Size
33.48 33 miles
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Duke University Recruiting
2
Trial Phase
500
Trial Size
33.48 33 miles
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients PLC Medical Systems, Inc. Recruiting
3
Trial Phase
326
Trial Size
33.48 33 miles
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation William Beaumont Hospitals Recruiting N/A
64
Trial Size
33.48 33 miles
A Registry of Patients With Primary Choroidal Melanoma (CM) or Indeterminate Lesions (ILs) Aura Biosciences Recruiting N/A
500
Trial Size
33.48 33 miles
A Multi-Center Trial of the ProLung Testâ„¢ Fresh Medical Laboratories Recruiting N/A
300
Trial Size
33.77 34 miles
The MENDSII Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Vanderbilt University Recruiting
3
Trial Phase
530
Trial Size
33.77 34 miles
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
3
Trial Phase
320
Trial Size
33.77 34 miles
Genomic Response Analysis of Heart Failure Therapy in African Americans University of Pittsburgh Recruiting N/A
500
Trial Size
33.77 34 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
33.77 34 miles
A Phase 4 Study of Ivabradine in African-American/Black's w/Heart Failure & Left Ventricular Systolic Dysfunction Amgen Recruiting
4
Trial Phase
30
Trial Size
33.77 34 miles
Breastfeeding Support and Weight Management for Black Women Michigan State University Recruiting N/A
60
Trial Size
33.77 34 miles
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting
1
Trial Phase
36
Trial Size
33.77 34 miles
Efficacy, Safety, and Tolerability of MRG-201 Following Intradermal Injection in Subjects With a History of Keloids miRagen Therapeutics, Inc. Recruiting
2
Trial Phase
12
Trial Size
33.77 34 miles
A Brief Intervention for Chronic Pain in Primary Care Henry Ford Health System Recruiting N/A
60
Trial Size
33.77 34 miles
Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function Henry Ford Health System Recruiting N/A
62
Trial Size
33.77 34 miles
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction Henry Ford Health System Recruiting
2
Trial Phase
100
Trial Size
33.77 34 miles
Nonopioid Analgesia After Rotator Cuff Repair Henry Ford Health System Recruiting
2
Trial Phase
100
Trial Size
33.77 34 miles
Nonopioid Analgesia After Arthroscopic Meniscus Surgery Henry Ford Health System Recruiting
1
Trial Phase
100
Trial Size
33.77 34 miles
Nonopioid Analgesia After Labral Surgery Henry Ford Health System Recruiting
2
Trial Phase
100
Trial Size
33.77 34 miles
Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant Henry Ford Health System Recruiting
2
Trial Phase
308
Trial Size
33.77 34 miles
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Henry Ford Health System Recruiting
2
Trial Phase
15
Trial Size
33.77 34 miles
Subscapularis Strength After Total Shoulder Arthroplasty Henry Ford Health System Recruiting N/A
60
Trial Size
33.77 34 miles
Student Anxiety & Stress Study Wayne State University Recruiting N/A
120
Trial Size
33.77 34 miles
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis University of Pittsburgh Recruiting
2
Trial Phase
40
Trial Size
34.23 34 miles
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Duke University Recruiting N/A
3000
Trial Size
34.23 34 miles
Evaluation of the Duration of Therapy for Thrombosis in Children University of Colorado, Denver Recruiting
3
Trial Phase
750
Trial Size
34.23 34 miles
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors Five Prime Therapeutics, Inc. Recruiting
1
Trial Phase
120
Trial Size
34.23 34 miles
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer Novartis Recruiting
1
Trial Phase
142
Trial Size
34.23 34 miles
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer ACEA Biosciences, Inc. Recruiting
1
Trial Phase
100
Trial Size
34.23 34 miles
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Novartis Recruiting
1
Trial Phase
100
Trial Size
34.23 34 miles
A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors Novartis Recruiting
1
Trial Phase
35
Trial Size
34.23 34 miles
Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Recruiting N/A
600
Trial Size
34.23 34 miles
Trial of Combination of Elotuzumab and Lenalidomide +/- Dexamethasone in High-Risk Smoldering Multiple Myeloma Dana-Farber Cancer Institute Recruiting
2
Trial Phase
82
Trial Size
34.23 34 miles
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors ImmunoGen, Inc. Recruiting
1
Trial Phase
205
Trial Size
34.23 34 miles
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors GlaxoSmithKline Recruiting
1
Trial Phase
200
Trial Size
34.23 34 miles
GSK1120212 Rollover Study GlaxoSmithKline Recruiting
2
Trial Phase
250
Trial Size
34.23 34 miles
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Novartis Available N/A
0
Trial Size
34.23 34 miles
Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms) Wayne State University Recruiting N/A
212
Trial Size
34.23 34 miles
CD40 Agonistic Antibody APX005M in Combination With Nivolumab Apexigen, Inc. Recruiting
1
Trial Phase
99
Trial Size
34.23 34 miles
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO) Pharmacyclics LLC. Recruiting
3
Trial Phase
287
Trial Size
34.23 34 miles
A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma Seattle Genetics, Inc. Recruiting
1
Trial Phase
75
Trial Size
34.23 34 miles
A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma Trillium Therapeutics Inc. Recruiting
1
Trial Phase
156
Trial Size
34.23 34 miles
Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA Wayne State University Recruiting N/A
80
Trial Size
34.23 34 miles
Brentuximab Vedotin and Nivolumab in Treating Participants With Early Stage Classic Hodgkin Lymphoma City of Hope Medical Center Recruiting
2
Trial Phase
264
Trial Size
34.23 34 miles
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Urovant Sciences GmbH Recruiting
3
Trial Phase
1088
Trial Size
34.82 35 miles
PACMAN Ultrasound Recording Data Collection Halyard Health Recruiting N/A
900
Trial Size
36.38 36 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
36.38 36 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
36.38 36 miles
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) ImmusanT, Inc. Recruiting
2
Trial Phase
146
Trial Size
36.38 36 miles
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
505
Trial Size
38.45 38 miles
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections The Medicines Company Recruiting
1
Trial Phase
60
Trial Size
41.04 41 miles
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension Arbor Pharmaceuticals, Inc. Recruiting
3
Trial Phase
260
Trial Size
41.04 41 miles
Study of Adjuvant Regorafenib vs Placebo in Patients With Node Positive Esophageal Cancer That Completed Pre-operative Therapy Academic and Community Cancer Research United Recruiting
2
Trial Phase
105
Trial Size
41.04 41 miles
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU Novartis Recruiting
2
Trial Phase
360
Trial Size
41.04 41 miles
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Shire Recruiting
3
Trial Phase
264
Trial Size
41.08 41 miles
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene Sienna Labs Recruiting
2
Trial Phase
60
Trial Size
41.66 42 miles
Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders Ascension South East Michigan Recruiting N/A
15
Trial Size
43.25 43 miles
The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine University of Toledo Health Science Campus Recruiting
4
Trial Phase
48
Trial Size
45.67 46 miles
Electromyography in Patients on Chronic Pyridostigmine Therapy University of Toledo Health Science Campus Recruiting
3
Trial Phase
50
Trial Size
45.67 46 miles
Fade Upon TOF Stimulation Induced by Succinylcholine University of Toledo Health Science Campus Recruiting
4
Trial Phase
50
Trial Size
45.67 46 miles
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers SerenaGroup, Inc. Recruiting
4
Trial Phase
194
Trial Size
45.67 46 miles
eFT508 in Combination With PD-1/PD-L1 Inhibitor Therapy Effector Therapeutics Recruiting
2
Trial Phase
40
Trial Size
45.67 46 miles
Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma Cordgenics, LLC Recruiting
3
Trial Phase
300
Trial Size
45.67 46 miles
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes BrainScope Company, Inc. Recruiting N/A
220
Trial Size
47.76 48 miles
Preventing Alzheimer's Disease With Cognitive Training University of South Florida Recruiting N/A
1600
Trial Size
47.76 48 miles
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Center for International Blood and Marrow Transplant Research Recruiting
3
Trial Phase
35000
Trial Size
50.90 51 miles
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
184
Trial Size
51.86 52 miles
Use of Handheld Audiovisual Devices to Treat Pediatric Preoperative Anxiety McLaren Health Care Recruiting
3
Trial Phase
200
Trial Size
52.06 52 miles
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis Mallinckrodt Recruiting
4
Trial Phase
232
Trial Size
52.06 52 miles
Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study Sparrow Clinical Research Institute Recruiting N/A
500
Trial Size
52.57 53 miles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) Genentech, Inc. Recruiting
2
Trial Phase
270
Trial Size
56.20 56 miles
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma National Cancer Institute (NCI) Recruiting
2
Trial Phase
160
Trial Size
74.75 75 miles
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment National Cancer Institute (NCI) Recruiting
3
Trial Phase
224
Trial Size
84.34 84 miles
A Phase 2 Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) Velicept Therapeutics, Inc. Recruiting
2
Trial Phase
1200
Trial Size
84.52 85 miles
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery KV Pharmaceutical Company Recruiting
3
Trial Phase
1707
Trial Size
84.67 85 miles
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery The Cleveland Clinic Recruiting
4
Trial Phase
1000
Trial Size
91.64 92 miles
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia Pharmacyclics Recruiting N/A
1500
Trial Size
96.55 97 miles
MLD10 in the Prevention of Migraine in Adults Pharmalyte Recruiting
2
Trial Phase
142
Trial Size
100.66 101 miles
Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC Hoosier Cancer Research Network Recruiting
2
Trial Phase
93
Trial Size
102.60 103 miles
A Trial of Hu5F9-G4 With Avelumab in Ovarian Cancer Forty Seven, Inc. Recruiting
1
Trial Phase
32
Trial Size
103.55 104 miles
Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies Jounce Therapeutics, Inc. Recruiting
1
Trial Phase
40
Trial Size
103.55 104 miles
Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge Spectrum Health Hospitals Recruiting N/A
125
Trial Size
103.55 104 miles
Prometra Post-Approval Study Flowonix Medical Recruiting N/A
400
Trial Size
104.79 105 miles
Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction Home Skinovations Ltd. Recruiting N/A
84
Trial Size
104.79 105 miles
ToothWave Plaque and Gingivitis Study Home Skinovations Ltd. Recruiting N/A
90
Trial Size
104.79 105 miles
Improving Parent-Child Interactions to Enhance Child Health Central Michigan University Recruiting N/A
75
Trial Size
107.24 107 miles
Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device Carticept Medical, Inc Recruiting N/A
120
Trial Size
108.87 109 miles
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma Hoosier Oncology Group Recruiting
1
Trial Phase
69
Trial Size
109.85 110 miles
The Impact of Low Pressure Pneumo in RARP Metro Health, Michigan Recruiting N/A
400
Trial Size
109.85 110 miles
Ascorbic Acid Levels in MDS, AML, and CMML Patients Van Andel Research Institute Recruiting N/A
50
Trial Size
109.85 110 miles
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease Bristol-Myers Squibb Recruiting
2
Trial Phase
240
Trial Size
109.85 110 miles
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) Edwards Lifesciences Recruiting N/A
1025
Trial Size
109.96 110 miles
Molecular-Guided Therapy for Childhood Cancer Spectrum Health Hospitals Recruiting N/A
56
Trial Size
109.96 110 miles
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Northwest Biotherapeutics Available N/A
0
Trial Size
109.96 110 miles
Zinc Sulfate for Human Papillomavirus (HPV) Spectrum Health Hospitals Recruiting N/A
138
Trial Size
109.96 110 miles
Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma Spectrum Health Hospitals Recruiting N/A
20
Trial Size
109.96 110 miles
Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA Spectrum Health Hospitals Recruiting N/A
172
Trial Size
109.96 110 miles
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases Spectrum Health Hospitals Recruiting
2
Trial Phase
15
Trial Size
109.96 110 miles
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds Arteriocyte, Inc. Recruiting N/A
1500
Trial Size
112.79 113 miles
Rasagiline Rescue in Alzheimer's Disease Clinical Trial The Cleveland Clinic Recruiting
2
Trial Phase
50
Trial Size
112.79 113 miles
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn) Biomet, Inc. Recruiting
4
Trial Phase
80
Trial Size
114.50 114 miles
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Forest Laboratories Recruiting
3
Trial Phase
1100
Trial Size
116.27 116 miles
A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE) Nektar Therapeutics Recruiting
1
Trial Phase
48
Trial Size
116.27 116 miles
Comparison of Three Balance Training Protocols for Individuals Post Stroke Cleveland State University Recruiting N/A
66
Trial Size
117.71 118 miles
Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL Immunomedics, Inc. Recruiting
1
Trial Phase
100
Trial Size
118.12 118 miles
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Baxalta US Inc. Recruiting
2
Trial Phase
90
Trial Size
118.12 118 miles
Stimulation With Wire Leads to Restore Cough [Redacted] Recruiting N/A
16
Trial Size
118.14 118 miles
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
800
Trial Size
118.14 118 miles
Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure Duke University Recruiting
3
Trial Phase
220
Trial Size
118.14 118 miles
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Duke University Recruiting
2
Trial Phase
360
Trial Size
118.14 118 miles
Registry of Avance Nerve Graft Evaluating Utilization and Outcomes for the Reconstruction of Peripheral Nerve Discontinuities AxoGen, Inc Recruiting N/A
500
Trial Size
118.14 118 miles
ATTR Expanded Access Program (EAP) by Ionis Ionis Pharmaceuticals, Inc. Available N/A
0
Trial Size
118.14 118 miles
Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV MetroHealth Medical Center Recruiting N/A
180
Trial Size
118.14 118 miles
Artisan Aphakia Lens for the Correction of Aphakia in Children Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
119.06 119 miles
Treatment Use of Domperidone for Gastroparesis The Cleveland Clinic Available N/A
0
Trial Size
119.95 120 miles
Selecting a Favorable KIR Donor in Unrelated HCT for AML Masonic Cancer Center, University of Minnesota Recruiting N/A
800
Trial Size
119.95 120 miles
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients APT Pharmaceuticals, Inc. Available N/A
0
Trial Size
119.95 120 miles
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations Arog Pharmaceuticals LLC Recruiting
2
Trial Phase
48
Trial Size
119.95 120 miles
ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) Alnylam Pharmaceuticals Recruiting
3
Trial Phase
200
Trial Size
119.95 120 miles
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones Mayo Clinic Recruiting N/A
150
Trial Size
119.95 120 miles
The Cyclical Lower-extremity Exercise for Parkinson's Trial The Cleveland Clinic Recruiting
2
Trial Phase
100
Trial Size
119.95 120 miles
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry Monteris Medical Recruiting N/A
300
Trial Size
119.95 120 miles
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System Monteris Medical Recruiting N/A
1000
Trial Size
119.95 120 miles
CorMatrix ECM Tricuspid Valve Replacement CorMatrix Cardiovascular, Inc. Recruiting
0
Trial Phase
15
Trial Size
119.95 120 miles
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation CareDx Recruiting N/A
300
Trial Size
119.95 120 miles
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis Case Comprehensive Cancer Center Recruiting
0
Trial Phase
42
Trial Size
119.95 120 miles
Evaluation of 3D Visualization for Total Colectomy The Cleveland Clinic Recruiting
4
Trial Phase
54
Trial Size
119.95 120 miles
Development & Testing of a Decision Aid for LVAD Placement Baylor College of Medicine Recruiting N/A
144
Trial Size
119.95 120 miles
Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery Baxter Healthcare Corporation Recruiting
3
Trial Phase
15
Trial Size
119.95 120 miles
New International CTEPH Database International CTEPH Association Recruiting N/A
800
Trial Size
119.95 120 miles
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases Case Comprehensive Cancer Center Recruiting
1
Trial Phase
40
Trial Size
119.95 120 miles
POSITIVE Stroke Clinical Trial Medical University of South Carolina Recruiting N/A
750
Trial Size
119.95 120 miles
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Associazione Angela Serra per la ricerca sul cancro Recruiting N/A
2000
Trial Size
119.95 120 miles
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients Fred Hutchinson Cancer Research Center Recruiting N/A
1000
Trial Size
119.95 120 miles
Treating Phantom Limb Pain Using Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study University of California, San Diego Recruiting
4
Trial Phase
180
Trial Size
119.95 120 miles
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer Case Comprehensive Cancer Center Recruiting
1
Trial Phase
24
Trial Size
119.95 120 miles
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Chimerix Available N/A
0
Trial Size
119.95 120 miles
A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis The Cleveland Clinic Recruiting N/A
50
Trial Size
119.95 120 miles
Correlation Between Peripheral Venous Pressure and Central Venous Pressure in the Cardiac Intensive Care Unit The Cleveland Clinic Recruiting N/A
30
Trial Size
119.95 120 miles
A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure The Cleveland Clinic Recruiting N/A
100
Trial Size
119.95 120 miles
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy Hoffmann-La Roche Recruiting
2
Trial Phase
100
Trial Size
119.95 120 miles
Accuracy of Commercially Available Heart Rate Monitors in Athletes The Cleveland Clinic Recruiting N/A
50
Trial Size
119.95 120 miles
Mirror Box Therapy as a Treatment Option for Functional Movement Disorders The Cleveland Clinic Recruiting N/A
14
Trial Size
119.95 120 miles
Same Day Discharge After Minimally-invasive Sacrocolpopexy The Cleveland Clinic Recruiting N/A
47
Trial Size
119.95 120 miles
Study of Ketorolac Versus Opioid for Pain After Endoscopy The Cleveland Clinic Recruiting
4
Trial Phase
80
Trial Size
119.95 120 miles
Parastomal Hernia Repair Utilizing the Retromuscular Sugarbaker Versus Keyhole Mesh Techniques The Cleveland Clinic Recruiting N/A
142
Trial Size
119.95 120 miles
A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch The Cleveland Clinic Recruiting N/A
50
Trial Size
119.95 120 miles
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Pfizer Available
4
Trial Phase
0
Trial Size
120.59 121 miles
Longitudinal Study of Urea Cycle Disorders Office of Rare Diseases (ORD) Recruiting
2
Trial Phase
1100
Trial Size
120.59 121 miles
Inspire® Post-Approval Study / Protocol Number 2014-001 Inspire Medical Systems, Inc. Recruiting
4
Trial Phase
127
Trial Size
120.59 121 miles
Treatment Adherence Enhancement in Bipolar Disorder University Hospitals of Cleveland Recruiting N/A
184
Trial Size
120.59 121 miles
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults City of Hope Medical Center Recruiting N/A
700
Trial Size
120.59 121 miles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
30
Trial Size
120.59 121 miles
Short-term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia Children's Research Institute Recruiting
2
Trial Phase
144
Trial Size
120.59 121 miles
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery National Cancer Institute (NCI) Recruiting N/A
45
Trial Size
120.59 121 miles
Neural Prostheses and Gait Performance: Model-Based Strategies Department of Veterans Affairs Recruiting N/A
10
Trial Size
120.59 121 miles
A Phase 1b/2, Study of Pegylated Recombinant Human Hyaluronidase Combined With Docetaxel Versus Docetaxel Alone in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC. Halozyme Therapeutics Recruiting
1
Trial Phase
238
Trial Size
120.59 121 miles
MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS) University Hospitals Cleveland Medical Center Recruiting N/A
24
Trial Size
120.59 121 miles
Safety of Immediate Skin-to-Skin Contact After Vaginal Birth in Vigorous Late-Preterm Neonates - A Pilot Study University Hospitals Cleveland Medical Center Recruiting N/A
92
Trial Size
120.59 121 miles
Transcranial Direct Current Stimulation for Post-stroke Gait Rehab VA Office of Research and Development Recruiting
2
Trial Phase
50
Trial Size
120.59 121 miles
The Effect of Abdominal Binder Use on Postoperative Pain and Mobility in Patients Undergoing Pelvic Surgery University Hospitals Cleveland Medical Center Recruiting N/A
88
Trial Size
120.59 121 miles
FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care University Hospitals Cleveland Medical Center Recruiting
4
Trial Phase
500
Trial Size
120.59 121 miles
Prematurity Education in High Risk Pregnancies University Hospitals Cleveland Medical Center Recruiting N/A
80
Trial Size
120.59 121 miles
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS Zynerba Pharmaceuticals, Inc. Recruiting
2
Trial Phase
300
Trial Size
120.59 121 miles
Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder University Hospitals Cleveland Medical Center Recruiting N/A
50
Trial Size
120.59 121 miles
FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for Psoriasis University Hospitals Cleveland Medical Center Recruiting N/A
35
Trial Size
120.59 121 miles
Hemoglobin Desaturation in Sickle Cell Disease University Hospitals Cleveland Medical Center Recruiting N/A
20
Trial Size
120.59 121 miles
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants Pfizer Recruiting
2
Trial Phase
460
Trial Size
122.46 122 miles
Evaluation of a Daily Oral Care Lozenge on Oral Health and Quality of Life in Older Adults Primal Therapies Inc. Recruiting N/A
60
Trial Size
122.88 123 miles
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Merck Recruiting
2
Trial Phase
1960
Trial Size
125.83 126 miles
Brain Imaging and Safety Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease TauRx Therapeutics Ltd Recruiting
2
Trial Phase
180
Trial Size
125.83 126 miles
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants Janssen Research & Development, LLC Recruiting
2
Trial Phase
440
Trial Size
125.83 126 miles
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
300
Trial Size
125.83 126 miles
Efficacy of a Plant-derived Quadrivalent VLP Vaccine in the Elderly Medicago Recruiting
3
Trial Phase
12120
Trial Size
125.83 126 miles
Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain Axogen Corporation Recruiting N/A
101
Trial Size
126.91 127 miles
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. Recruiting
4
Trial Phase
790
Trial Size
131.72 132 miles
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study Pfizer Recruiting
3
Trial Phase
500
Trial Size
132.11 132 miles
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
37
Trial Size
135.60 136 miles
Thiamine, Vitamin C and Hydrocortisone in the Treatment of Septic Shock Lakeland Health Recruiting N/A
60
Trial Size
141.80 142 miles
Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population Johnson & Johnson Vision Care, Inc. Recruiting N/A
135
Trial Size
147.83 148 miles
Apioc Toric/Spherical Single Vision Contact Lens Lentechs, LLC Recruiting N/A
70
Trial Size
147.83 148 miles
Healthy Heart Score Intervention In the Primary Care Setting Ohio University Recruiting N/A
100
Trial Size
150.98 151 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
150.98 151 miles
Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome Nationwide Children's Hospital Recruiting N/A
58
Trial Size
152.42 152 miles
An Open-label, Phase 2a/2b Study of KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed Ruxolitinib Kartos Therapeutics, Inc. Recruiting
2
Trial Phase
190
Trial Size
152.68 153 miles
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Array BioPharma Recruiting
1
Trial Phase
42
Trial Size
152.68 153 miles
A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label AVEO Pharmaceuticals, Inc. Recruiting
2
Trial Phase
86
Trial Size
156.32 156 miles
Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) Boston Scientific Corporation Recruiting
2
Trial Phase
100
Trial Size
156.71 157 miles
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Geno LLC Recruiting
2
Trial Phase
75
Trial Size
158.91 159 miles
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 Isis Pharmaceuticals Recruiting
1
Trial Phase
80
Trial Size
158.91 159 miles
Study of Suture Repair of Torn Meniscus in the Knee Ceterix Orthopaedics, Inc. Recruiting N/A
30
Trial Size
158.91 159 miles
Answer ALS: Individualized Initiative for ALS Discovery Johns Hopkins University Recruiting N/A
1000
Trial Size
158.91 159 miles
Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures Ohio State University Recruiting N/A
1500
Trial Size
158.91 159 miles
Exploring New and Next Generation Ultrasound Technologies for Medical Education, Patient Care, and New Indications Ohio State University Recruiting N/A
750
Trial Size
158.91 159 miles
Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures Ohio State University Recruiting N/A
400
Trial Size
158.91 159 miles
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging Ohio State University Recruiting N/A
700
Trial Size
158.91 159 miles
Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects Ohio State University Recruiting N/A
5000
Trial Size
158.91 159 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
158.91 159 miles
SCP Hip Outcomes Study Zimmer Biomet Recruiting N/A
100
Trial Size
159.08 159 miles
Nonarthritic Hip Disease Evaluation And Treatment Ohio State University Recruiting N/A
96
Trial Size
159.08 159 miles
A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Vericel Corporation Recruiting
3
Trial Phase
45
Trial Size
159.08 159 miles
Immune Responses to the Flu Shot During Pregnancy Ohio State University Recruiting N/A
180
Trial Size
159.80 160 miles
Genetic Influence on Statin Pharmacokinetics Ohio State University Recruiting N/A
800
Trial Size
160.01 160 miles
Examining How Motor Rehabilitation Promotes Brain Reorganization Following Stroke, an MRI Study Ohio State University Recruiting N/A
74
Trial Size
160.01 160 miles
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event Ohio State University Recruiting
1
Trial Phase
210
Trial Size
160.01 160 miles
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin Ohio State University Comprehensive Cancer Center Recruiting N/A
60
Trial Size
160.01 160 miles
Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea (OSA) Ohio State University Recruiting N/A
72
Trial Size
160.01 160 miles
Esthesioneuroblastoma: Outcomes After Treatment Ohio State University Recruiting N/A
100
Trial Size
160.01 160 miles
Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Ohio State University Comprehensive Cancer Center Recruiting
1
Trial Phase
59
Trial Size
160.01 160 miles
The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis Ohio State University Recruiting
1
Trial Phase
64
Trial Size
160.01 160 miles
Longitudinal Pancreatic Cancer Study Fujirebio Diagnostics, Inc. Recruiting N/A
140
Trial Size
160.01 160 miles
Study of APD421 as PONV Treatment (no Prior Prophylaxis) Acacia Pharma Ltd Recruiting
3
Trial Phase
580
Trial Size
160.01 160 miles
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns MediWound Ltd Recruiting
3
Trial Phase
175
Trial Size
160.01 160 miles
Physiological Brain Atlas Development Ohio State University Recruiting N/A
500
Trial Size
160.01 160 miles
PF-04449913 For Patients With Acute Leukemia at High Risk of Relapse After Donor Stem Cell Transplant University of Colorado, Denver Recruiting
2
Trial Phase
28
Trial Size
160.01 160 miles
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema Centre for Research & Implementation of Clinical Practice Recruiting
4
Trial Phase
262
Trial Size
160.01 160 miles
Virtual Temporal Bone Surgery: Defining and Translating Metrics Nationwide Children's Hospital Recruiting
1
Trial Phase
170
Trial Size
160.01 160 miles
Syncardia 50cc TAH-t as a Bridge to Transplant SynCardia Systems. Inc. Recruiting N/A
72
Trial Size
160.01 160 miles
Biomarkers for Gynecologic Cancer Ajinomoto Co., Inc. Recruiting N/A
160
Trial Size
160.01 160 miles
Statin Use in Patients With Acute VTE Ohio State University Recruiting
1
Trial Phase
80
Trial Size
160.01 160 miles
Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy Ohio State University Comprehensive Cancer Center Recruiting
4
Trial Phase
80
Trial Size
160.01 160 miles
Neoadjuvant GMCI Plus mFOLFIRINOX and Chemoradiation for Non-Metastatic Pancreatic Adenocarcinoma Advantagene, Inc. Recruiting
1
Trial Phase
44
Trial Size
160.01 160 miles
Correlative Biomarker Study in Patients With Myeloproliferative Disorders Myeloproliferative Disorders-Research Consortium Recruiting N/A
860
Trial Size
160.01 160 miles
Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Ohio State University Comprehensive Cancer Center Recruiting
2
Trial Phase
50
Trial Size
160.01 160 miles
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues Ohio State University Recruiting N/A
500
Trial Size
160.01 160 miles
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms Ohio State University Recruiting N/A
165
Trial Size
160.01 160 miles
Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Ohio State University Comprehensive Cancer Center Recruiting N/A
45
Trial Size
160.01 160 miles
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Roswell Park Cancer Institute Recruiting
1
Trial Phase
54
Trial Size
160.01 160 miles
True North, a research study for adults 18-75 with Ulcerative Colitis Celgene Recruiting
3
Trial Phase
900
Trial Size
160.01 160 miles
Controlled Trial Evaluating Avacopan in C3 Glomerulopathy ChemoCentryx Recruiting
2
Trial Phase
44
Trial Size
160.01 160 miles
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease Voyager Therapeutics Recruiting
1
Trial Phase
16
Trial Size
160.01 160 miles
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma H. Lee Moffitt Cancer Center and Research Institute Recruiting
1
Trial Phase
52
Trial Size
160.01 160 miles
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Genentech, Inc. Recruiting
2
Trial Phase
240
Trial Size
160.01 160 miles
Prospective Follow-up of Elderly Patients Undergoing Instrumented Lumbar Arthrodesis Supplemented by the Implanet Jazz System(TM) Ohio State University Recruiting N/A
100
Trial Size
160.01 160 miles
High-resolution MRI of Atrial Fibrillation Patients Prior to Focal Impulse and Rotor Modulation (FIRM) Ablation Ohio State University Recruiting N/A
20
Trial Size
160.01 160 miles
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD University of Kansas Medical Center Recruiting N/A
150
Trial Size
160.01 160 miles
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types Johnson & Johnson Vision Care, Inc. Recruiting
4
Trial Phase
120
Trial Size
160.01 160 miles
Diabetic Foot Ulcer Recurrence: Pilot Study Ohio State University Recruiting N/A
30
Trial Size
160.01 160 miles
Design of a Standardized Patient: Mentoring Program for Kidney Transplant Patients Ohio State University Recruiting N/A
150
Trial Size
160.01 160 miles
Same Day Subcutaneous ICD And Send Home (DASH) Ohio State University Recruiting N/A
40
Trial Size
160.01 160 miles
Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery Ohio State University Comprehensive Cancer Center Recruiting N/A
50
Trial Size
160.01 160 miles
Heart Failure Insomnia Treatment Study Ohio State University Recruiting N/A
200
Trial Size
160.01 160 miles
Feasibility and Preliminary Efficacy of Support Figure Attendance at Bariatric Patients' Clinical Visits Ohio State University Recruiting N/A
440
Trial Size
160.01 160 miles
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer Ohio State University Comprehensive Cancer Center Recruiting
2
Trial Phase
60
Trial Size
160.01 160 miles
A Study for the Production of a Personalized Neoantigen Cancer Vaccine Gritstone Oncology, Inc. Recruiting N/A
40
Trial Size
160.01 160 miles
REtroperitoneal SArcoma Registry: an International Prospective Initiative Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting N/A
2000
Trial Size
160.01 160 miles
Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD) Ohio State University Recruiting N/A
45
Trial Size
160.01 160 miles
PoNS Clinical Experience Program (TBI) Neurohabilitation Corporation Recruiting N/A
20
Trial Size
160.01 160 miles
Use of Lumbar Motion Monitor to Predict Response to Radiofrequency Ablation After Medial Branch Diagnostic Blocks Ohio State University Recruiting N/A
300
Trial Size
160.01 160 miles
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Virginia Commonwealth University Recruiting N/A
650
Trial Size
160.01 160 miles
Dietary Supplementation in Heart Failure Ohio State University Recruiting N/A
60
Trial Size
160.01 160 miles
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Agendia Recruiting N/A
1200
Trial Size
160.92 161 miles
Atrasentan Spermatogenesis and Testicular Function AbbVie Recruiting
2
Trial Phase
20
Trial Size
160.92 161 miles
Gene Transfer Study of AAV9-CLN3 for Treatment NCL Type 3 Nationwide Children's Hospital Recruiting
1
Trial Phase
7
Trial Size
161.17 161 miles
Expanded Access Program With Nivolumab to Treat Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
161.20 161 miles
Motivational Interviewing and Vaccine Hesitancy in Children Cedarville University Recruiting N/A
347
Trial Size
162.42 162 miles
HostDxTM Fever in Acute Respiratory Infections Inflammatix Recruiting N/A
235
Trial Size
162.48 162 miles
Arthrex Eclipseâ„¢ Shoulder Prosthesis Arthrex, Inc. Recruiting N/A
350
Trial Size
162.94 163 miles
Critical Smoke Alarm Characteristics to Awaken Children From Stage 4 Sleep Nationwide Children's Hospital Recruiting N/A
708
Trial Size
163.87 164 miles
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma Ann & Robert H Lurie Children's Hospital of Chicago Recruiting
3
Trial Phase
160
Trial Size
163.87 164 miles
Genetics of Congenital Heart Disease Nationwide Children's Hospital Recruiting N/A
1000
Trial Size
163.87 164 miles
Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial Nationwide Children's Hospital Recruiting N/A
120
Trial Size
163.87 164 miles
Pilot Evaluation of the FilmArray® Febrile Infant (FI) Panel BioFire Diagnostics, LLC Recruiting N/A
500
Trial Size
163.87 164 miles
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
194
Trial Size
163.87 164 miles
Opioid Consumption After Knee Arthroscopy Nationwide Children's Hospital Recruiting N/A
40
Trial Size
163.87 164 miles
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Genentech, Inc. Available N/A
0
Trial Size
163.87 164 miles
Fatty Acid Supplementation in Children With ASD Nationwide Children's Hospital Recruiting
4
Trial Phase
66
Trial Size
163.87 164 miles
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease Nationwide Children's Hospital Recruiting N/A
100
Trial Size
163.87 164 miles
Gene Transfer Clinical Trial for LGMD2E (Beta-sarcoglycan Deficiency) Using scAAVrh74.MHCK7.hSGCB Nationwide Children's Hospital Recruiting
1
Trial Phase
9
Trial Size
163.87 164 miles
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis University of Iowa Recruiting N/A
860
Trial Size
163.87 164 miles
Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease Nationwide Children's Hospital Recruiting N/A
30
Trial Size
163.87 164 miles
Rituximab and Belimumab for Lupus Nephritis National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
2
Trial Phase
40
Trial Size
164.42 164 miles
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) Enyo Pharma Recruiting
2
Trial Phase
160
Trial Size
164.42 164 miles
Biology of Juvenile Myoclonic Epilepsy King's College London Recruiting N/A
1000
Trial Size
172.46 172 miles
Comparing Dry Needling to Manual Therapy for Patients With Mechanical Low Back Pain Youngstown State University Recruiting N/A
100
Trial Size
174.96 175 miles
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Novartis Recruiting N/A
3600
Trial Size
175.27 175 miles
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia Wright State Physicians Recruiting N/A
72
Trial Size
175.52 176 miles
Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically Dayton Interventional Radiology Recruiting N/A
5
Trial Size
176.90 177 miles
Phase 3 Study of BGB-A317 Versus Sorafenib in Patients With Unresectable HCC BeiGene Recruiting
3
Trial Phase
660
Trial Size
176.90 177 miles
Mind Body Interventions for the Student Population Youngstown State University Recruiting N/A
20
Trial Size
177.74 178 miles
Clinical Trial Evaluating the Effect of Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers Professional Education and Research Institute Recruiting N/A
40
Trial Size
177.82 178 miles
A Study to Determine Preferences Towards Interface Products Philips Respironics Recruiting N/A
250
Trial Size
177.82 178 miles
Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging Navidea Biopharmaceuticals Recruiting
2
Trial Phase
105
Trial Size
178.89 179 miles
Core Stabilization for the Treatment of Anterior Knee Pain Youngstown State University Recruiting N/A
50
Trial Size
181.72 182 miles
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Pfizer Available
3
Trial Phase
0
Trial Size
182.30 182 miles
Persona TM Tibia Clinical Outcomes Study Zimmer Biomet Recruiting N/A
96
Trial Size
182.38 182 miles
Evaluation of Conventional and Long Pulse Widths During a Temporary Spinal Cord Stimulation Trial Kettering Health Network Recruiting N/A
15
Trial Size
182.67 183 miles
PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness University of Pittsburgh Recruiting N/A
1000
Trial Size
186.05 186 miles
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program Exact Sciences Corporation Recruiting N/A
1500
Trial Size
186.10 186 miles
Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches Florida Gulf Coast University Recruiting N/A
64
Trial Size
188.63 189 miles
Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth Atrium Innovations Recruiting
1
Trial Phase
10
Trial Size
198.33 198 miles
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) Northwestern University Recruiting N/A
500
Trial Size
201.67 202 miles
Language in Primary Progressive Aphasia National Institute on Aging (NIA) Recruiting N/A
300
Trial Size
201.67 202 miles
Combined Spinal Epidural Urinary Retention Northwestern University Recruiting N/A
200
Trial Size
201.67 202 miles
A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM) Audentes Therapeutics Recruiting N/A
100
Trial Size
201.67 202 miles
Methotrexate and Mycophenolate Mofetil for UVEITIS University of California, San Francisco Recruiting
3
Trial Phase
216
Trial Size
201.67 202 miles
Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Avid Radiopharmaceuticals Recruiting
2
Trial Phase
1800
Trial Size
201.67 202 miles
Abdominal Ultrasound Assessment in the Post-cesarean Patient Northwestern University Recruiting N/A
500
Trial Size
201.67 202 miles
Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety Northwestern University Recruiting N/A
30
Trial Size
201.67 202 miles
SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Biotie Therapies Inc. Recruiting
2
Trial Phase
80
Trial Size
201.67 202 miles
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma Dynavax Technologies Corporation Recruiting
1
Trial Phase
31
Trial Size
201.67 202 miles
A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy Isis Pharmaceuticals Recruiting
3
Trial Phase
117
Trial Size
201.67 202 miles
Magna Mitral - 23mm Edwards Lifesciences Recruiting N/A
20
Trial Size
201.67 202 miles
Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma Northwestern University Recruiting
1
Trial Phase
48
Trial Size
201.67 202 miles
Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation Northwestern University Recruiting
4
Trial Phase
1002
Trial Size
201.67 202 miles
Circadian Rhythms and Sleep in Familial DSPS and ASPS National Heart, Lung, and Blood Institute (NHLBI) Recruiting N/A
156
Trial Size
201.67 202 miles
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity Northwestern University Recruiting
2
Trial Phase
560
Trial Size
201.67 202 miles
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection AIDS Clinical Trials Group Recruiting
1
Trial Phase
50
Trial Size
201.67 202 miles
Restricted Convalescence: Outcomes Following Urogynecologic Procedures Northwestern University Recruiting N/A
104
Trial Size
201.67 202 miles
Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries Northwestern University Recruiting
0
Trial Phase
100
Trial Size
201.67 202 miles
Misoprostol for Reduction of Blood Loss During Fibroid Surgery Northwestern University Recruiting
4
Trial Phase
50
Trial Size
201.67 202 miles
Identification of Novel Circadian Biomarkers Northwestern University Recruiting N/A
30
Trial Size
201.67 202 miles
A Mobile Behavioral Monitoring Intervention for Bipolar Disorder Northwestern University Recruiting
1
Trial Phase
48
Trial Size
201.67 202 miles
Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients Northwestern University Recruiting N/A
1000
Trial Size
201.67 202 miles
Chemokine Mechanisms in Chronic Pelvic Pain Northwestern University Recruiting N/A
264
Trial Size
201.67 202 miles
Effects of Thymoglobulin on Human B Cells Northwestern University Recruiting N/A
15
Trial Size
201.67 202 miles
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Northwestern University Recruiting
2
Trial Phase
35
Trial Size
201.67 202 miles
Circulating microRNAs as Disease Markers in Pediatric Cancers Ann & Robert H Lurie Children's Hospital of Chicago Recruiting N/A
20
Trial Size
201.67 202 miles
Longitudinal Study of Biomarkers Ann & Robert H Lurie Children's Hospital of Chicago Recruiting N/A
100
Trial Size
201.67 202 miles
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements University of Minnesota - Clinical and Translational Science Institute Recruiting N/A
30
Trial Size
201.67 202 miles
Community Engagement for Early Recognition and Immediate Action in Stroke Northwestern University Recruiting N/A
1000
Trial Size
201.67 202 miles
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients Northwestern University Recruiting N/A
1000
Trial Size
201.67 202 miles
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papillomavirus-Related Cancer in Adult Women After Kidney Transplant National Cancer Institute (NCI) Recruiting
2
Trial Phase
180
Trial Size
201.67 202 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
201.67 202 miles
FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma Big Ten Cancer Research Consortium Recruiting
2
Trial Phase
39
Trial Size
201.67 202 miles
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke Northwestern University Recruiting N/A
96
Trial Size
201.67 202 miles
Integrating Text Messages Into the Mothers and Babies Course Northwestern University Recruiting N/A
156
Trial Size
201.67 202 miles
Measuring Health Related Quality of Life in AYAs Wake Forest University Health Sciences Recruiting N/A
108
Trial Size
201.67 202 miles
Aging Program Project Grant 6 Northwestern University Recruiting N/A
100
Trial Size
201.67 202 miles
Strengthening Circadian Signals Northwestern University Recruiting N/A
100
Trial Size
201.67 202 miles
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia Northwestern University Recruiting
4
Trial Phase
50
Trial Size
201.67 202 miles
The Intensive Comprehensive Aphasia Program (ICAP) Shirley Ryan AbilityLab Recruiting N/A
56
Trial Size
201.67 202 miles
Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers Northwestern University Recruiting N/A
200
Trial Size
201.67 202 miles
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS) Ann & Robert H Lurie Children's Hospital of Chicago Recruiting N/A
200
Trial Size
201.67 202 miles
Wellness For 2: A Feasibility and Acceptability Pilot Northwestern University Recruiting N/A
30
Trial Size
201.67 202 miles
Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection Allergan Recruiting
1
Trial Phase
12
Trial Size
201.67 202 miles
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102 Ziopharm Recruiting
1
Trial Phase
18
Trial Size
201.67 202 miles
A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury Shirley Ryan AbilityLab Recruiting N/A
125
Trial Size
201.67 202 miles
Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants Ann & Robert H Lurie Children's Hospital of Chicago Recruiting N/A
120
Trial Size
201.67 202 miles
Nifedipine Metabolism in Pregnancy Northwestern University Recruiting N/A
65
Trial Size
201.67 202 miles
Noninvasive Spinal Stimulation in Stroke Shirley Ryan AbilityLab Recruiting N/A
45
Trial Size
201.67 202 miles
Investigation Into an Innovative, Clinical Slip Inducing Device in the Chronic Incomplete Spinal Cord Population Shirley Ryan AbilityLab Recruiting N/A
10
Trial Size
201.67 202 miles
Genetic Analysis of Pediatric Psoriasis Northwestern University Recruiting N/A
150
Trial Size
201.67 202 miles
Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI Shirley Ryan AbilityLab Recruiting
1
Trial Phase
24
Trial Size
201.67 202 miles
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections Duke University Recruiting N/A
400
Trial Size
201.67 202 miles
Autologous Transplant To End NMO Spectrum Disorder Northwestern University Recruiting
2
Trial Phase
50
Trial Size
201.67 202 miles
Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence Northwestern University Recruiting N/A
50
Trial Size
201.67 202 miles
Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Shionogi Inc. Recruiting
1
Trial Phase
18
Trial Size
201.67 202 miles
Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction Northwestern University Recruiting N/A
60
Trial Size
201.67 202 miles
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative University of Alberta Recruiting N/A
250
Trial Size
201.67 202 miles
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita Palvella Therapeutics, Inc. Recruiting
2
Trial Phase
60
Trial Size
201.67 202 miles
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant Emory University Recruiting
2
Trial Phase
27
Trial Size
201.67 202 miles
C-Brace Spinal Cord Injury Shirley Ryan AbilityLab Recruiting N/A
30
Trial Size
201.67 202 miles
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Northwestern University Recruiting N/A
300
Trial Size
201.67 202 miles
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma Ziopharm Recruiting
2
Trial Phase
30
Trial Size
201.67 202 miles
Outcome of BCF Access in Hemodialysis Patients University of Chicago Recruiting N/A
250
Trial Size
202.02 202 miles
Impact of the CommunityRx Program on Health, Service Utilization and Costs University of Chicago Recruiting N/A
200000
Trial Size
202.02 202 miles
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Vanderbilt-Ingram Cancer Center Recruiting
1
Trial Phase
74
Trial Size
202.02 202 miles
A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma Novartis Recruiting
1
Trial Phase
77
Trial Size
202.02 202 miles
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant University of Chicago Recruiting
1
Trial Phase
30
Trial Size
202.02 202 miles
Genetic Analysis-Guided Dosing of FOLFIRABAX in Treating Patients With Advanced Gastrointestinal Cancer University of Chicago Recruiting
1
Trial Phase
51
Trial Size
202.02 202 miles
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant University of Chicago Recruiting
1
Trial Phase
45
Trial Size
202.02 202 miles
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing University of Chicago Recruiting N/A
1200
Trial Size
202.02 202 miles
Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer University of Chicago Recruiting
1
Trial Phase
24
Trial Size
202.02 202 miles
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer University of Chicago Recruiting N/A
40
Trial Size
202.02 202 miles
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy University of Chicago Recruiting N/A
1000
Trial Size
202.02 202 miles
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation Astellas Pharma Inc Recruiting
3
Trial Phase
369
Trial Size
202.02 202 miles
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation [Redacted] Recruiting N/A
192
Trial Size
202.02 202 miles
Home Sleep and Metabolism University of Chicago Recruiting N/A
210
Trial Size
202.02 202 miles
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma University of Chicago Recruiting
2
Trial Phase
55
Trial Size
202.02 202 miles
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Astellas Pharma Inc Available N/A
0
Trial Size
202.02 202 miles
Axicabtagene Ciloleucel Expanded Access Study Kite Pharma, Inc. Available N/A
0
Trial Size
202.02 202 miles
Endoscopic Pyloromyotomy for Refractory Gastroparesis Institute for Clinical and Experimental Medicine Recruiting N/A
86
Trial Size
202.02 202 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
202.02 202 miles
Study to Develop Head Stabilizer for Use During Brain Radiation Therapy University of Chicago Recruiting N/A
20
Trial Size
202.02 202 miles
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness University of Chicago Recruiting N/A
200
Trial Size
202.02 202 miles
Effect of Stimulant Drugs on Social Perception University of Chicago Recruiting
1
Trial Phase
40
Trial Size
202.02 202 miles
Mood Effects of Serotonin Agonists University of Chicago Recruiting
1
Trial Phase
40
Trial Size
202.02 202 miles
Behavior Brain Responses University of Chicago Recruiting
1
Trial Phase
30
Trial Size
202.02 202 miles
A Study to Evaluate the Safety and Efficacy of SB206 in Children and Adolescents With Molluscum Contagiosum Novan, Inc. Recruiting
2
Trial Phase
256
Trial Size
202.05 202 miles
Latera RCT - Latera® Absorbable Nasal Implant vs. Sham Control for Lateral Nasal Valve Collapse Spirox, Inc. Recruiting N/A
150
Trial Size
202.06 202 miles
3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) CDA Research Group, Inc. Recruiting
1
Trial Phase
30
Trial Size
202.06 202 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
202.40 202 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
202.40 202 miles
High-Intensity Focused Electromagnetic (HIFEM) Field Device in Women After Childbirth BTL Industries Ltd. Recruiting N/A
25
Trial Size
202.41 202 miles
Acute Strawberry Intake on Endothelial Function Institute for Food Safety and Health, United States Recruiting N/A
15
Trial Size
202.56 203 miles
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response Institute for Food Safety and Health, United States Recruiting N/A
36
Trial Size
202.56 203 miles
Acute Berry Intake on Metabolic Control and Cognitive Function Institute for Food Safety and Health, United States Recruiting N/A
30
Trial Size
202.56 203 miles
Spices, Inflammation and Vascular Response in Humans Institute for Food Safety and Health, United States Recruiting N/A
20
Trial Size
202.56 203 miles
Interpersonal Relationships Intervention and Cardiovascular Health Northwestern University Recruiting N/A
500
Trial Size
202.98 203 miles
Comparison of the Classic Face Mask Versus NuMask for Preoxygenation Nimmagadda, Usharani, M.D. Recruiting N/A
30
Trial Size
202.99 203 miles
Open-Table, Single-Arm, Single-Center Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain Relievant Medsystems, Inc. Recruiting N/A
50
Trial Size
203.03 203 miles
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions AIDS Malignancy Clinical Trials Consortium Recruiting N/A
80
Trial Size
203.07 203 miles
Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women Harvard School of Public Health Recruiting N/A
3400
Trial Size
203.07 203 miles
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) Harvard School of Public Health Recruiting N/A
850
Trial Size
203.07 203 miles
TODAY! A Mobile App Study Ann & Robert H Lurie Children's Hospital of Chicago Recruiting N/A
50
Trial Size
203.07 203 miles
Understanding How Cognitive Remediation Works Boston University Recruiting N/A
244
Trial Size
203.14 203 miles
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness Dartmouth-Hitchcock Medical Center Recruiting N/A
174
Trial Size
203.14 203 miles
Bioavailability of EPA + DHA in a SMEDS Formulation Midwest Center for Metabolic and Cardiovascular Research Recruiting
4
Trial Phase
24
Trial Size
203.28 203 miles
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses Midwest Center for Metabolic and Cardiovascular Research Recruiting N/A
40
Trial Size
203.28 203 miles
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2) ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
280
Trial Size
203.28 203 miles
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model Faes Farma, S.A. Recruiting
3
Trial Phase
225
Trial Size
203.81 204 miles
Oropharyngeal Administration of Mother's Colostrum for Premature Infants NorthShore University HealthSystem Recruiting N/A
622
Trial Size
204.31 204 miles
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies University of Chicago Recruiting
1
Trial Phase
45
Trial Size
204.31 204 miles
Biology, Identity & Opportunity Study Northwestern University Recruiting N/A
300
Trial Size
204.31 204 miles
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI OPKO Ireland Global Holdings Ltd. Recruiting
2
Trial Phase
256
Trial Size
204.31 204 miles
Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease University of Illinois at Chicago Recruiting N/A
350
Trial Size
204.58 205 miles
Pilot Evaluation of an Interactive Health Game University of Illinois at Chicago Recruiting N/A
30
Trial Size
204.58 205 miles
Blood Flow in Individuals With Down Syndrome University of Illinois at Chicago Recruiting N/A
70
Trial Size
204.58 205 miles
Supportive Release Center Study University of Chicago Recruiting N/A
14400
Trial Size
204.58 205 miles
Engaging Self-regulation Targets to Improve Mood and Weight and Understand Mechanism in Depressed and Obese Adults University of Illinois at Chicago Recruiting N/A
105
Trial Size
204.58 205 miles
Research Tissue Bank Myeloproliferative Disorders-Research Consortium Recruiting N/A
400
Trial Size
205.09 205 miles
JOURNEYâ„¢ II CR Total Knee System Smith & Nephew, Inc. Recruiting N/A
170
Trial Size
205.09 205 miles
Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection National Cancer Institute (NCI) Recruiting
1
Trial Phase
26
Trial Size
205.09 205 miles
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease University of Miami Recruiting N/A
175
Trial Size
205.09 205 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.